SCHEMBL13487170

SCHEMBL13487170

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4ccccn4)c4ccc(-c5cccc6ccccc56)cc34)cccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.42
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TGFBR1 P36897 3/20 0.37
PDK2 Q15119 1/20 0.35
ENPP1 P22413 2/20 0.34
ENPP3 O14638 1/20 0.34
DCTPP1 Q9H773 1/20 0.34
DHODH Q02127 1/20 0.33
CCNT1 O60563 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CDK9 P50750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487207 0.94 HTR2C (0.39) HTR2CKDM4ENPC1ALDH1A1TP53
SCHEMBL13487273 0.90 KDM4E (0.38) HTR2CKDM4ENPC1ALDH1A1TP53
SCHEMBL13487175 0.90 HTR2C (0.36) HTR2CKDM4ENPC1ALDH1A1TP53
SCHEMBL13487176 0.90 ALOX5AP (0.34) HTR2CKDM4EALDH1A1MAPTHPGD
SCHEMBL13487177 0.89 ENPP1 (0.33) HTR2CKDM4ENPC1ALDH1A1MAPT
SCHEMBL13487980 0.89 HTR2C (0.42) HTR2CKDM4ENPC1ALDH1A1TP53
SCHEMBL13487102 0.89 PDK2 (0.36) HTR2CKDM4EALDH1A1TP53MAPT
SCHEMBL13487353 0.89 PDK2 (0.41) HTR2CKDM4ENPC1ALDH1A1TP53
SCHEMBL13487594 0.88 HTR2C (0.41) HTR2CKDM4ENPC1ALDH1A1TP53
SCHEMBL13487173 0.88 CCR1 (0.32) HTR2CKDM4ENPC1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 HTR2C 4442/4885KDM4E 3671/4885NPC1 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.